Mette T Faber
Overview
Explore the profile of Mette T Faber including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
228
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bennetsen A, Faber M, Nygaard M, Sundstrom K, Hansen B, Thomsen L, et al.
Scand J Public Health
. 2023 May;
52(5):616-623.
PMID: 37165576
Aims: Teenage pregnancy may have negative consequences for the mother and the infant. The aim of the study was to examine whether selected individual factors occurring early in life were...
2.
McClymont E, Faber M, Belmonte F, Kjaer S
BJOG
. 2022 Nov;
130(4):358-365.
PMID: 36424904
Objective: To determine whether prior human papillomavirus (HPV) vaccination contributes to preterm birth risk. Design: Population-based retrospective cohort study. Setting: Denmark. Population: A cohort of 243 136 primiparous females born...
3.
McClymont E, Faber M, Lindquist S, Bone J, Kjaer S
J Acquir Immune Defic Syndr
. 2022 Sep;
91(2):122-129.
PMID: 36094477
Background: In the general population, human papillomavirus (HPV) prevalence is reportedly increased during pregnancy, and emerging evidence suggests that it may be associated with adverse pregnancy outcomes. Women living with...
4.
Faber M, Frederiksen K, Palefsky J, Kjaer S
Int J Cancer
. 2022 Jun;
151(8):1240-1247.
PMID: 35657350
Little is known about risk factors for progression of high-grade anal intraepithelial neoplasia (AIN) to anal squamous cell carcinoma (ASCC). In this large, population-based study, we assess the role of...
5.
Robles C, Bruni L, Acera A, Riera J, Prats L, Poljak M, et al.
Am J Prev Med
. 2020 Dec;
60(4):478-487.
PMID: 33358719
Introduction: Human papillomavirus-vaccinated cohorts, irrespective of age, will likely reduce their subsequent screening requirements, thus opening opportunities for global cost reduction and program sustainability. The determinants of uptake and completion...
6.
Baandrup L, Faber M, Aalborg G, Kjaer S
Acta Obstet Gynecol Scand
. 2020 Oct;
100(3):436-443.
PMID: 33010027
Introduction: After some decades with an increasing incidence of borderline ovarian tumors, more recent studies have observed that the incidence rate seems to be leveling off or declining. In this...
7.
Faber M, Kjaer A, Larsen H, Thomsen L, Haedersdal M, Bonde J, et al.
Oral Dis
. 2019 Nov;
26(2):484-488.
PMID: 31742827
Objective: To assess the prevalence and type distribution of oral human papillomavirus (HPV) among renal transplant recipients (RTRs) and healthy controls and to examine risk factors for oral HPV among...
8.
Faber M, Frederiksen K, Palefsky J, Kjaer S
Cancer Epidemiol Biomarkers Prev
. 2019 Oct;
29(1):185-192.
PMID: 31597665
Background: Human papillomavirus (HPV) is associated with the majority of anal high-grade intraepithelial neoplasia (AIN) and anal cancers. Little is known about the risk of anal cancer following a diagnosis...
9.
Faber M, Sand F, Albieri V, Norrild B, Kjaer S, Verdoodt F
Int J Cancer
. 2017 Jun;
141(6):1161-1169.
PMID: 28577297
In this updated systematic review and meta-analysis, we estimate the pooled prevalence of human papillomavirus (HPV) DNA and HPV type distribution in squamous cell carcinoma of the vulva (vulvar cancer)...
10.
Svahn M, Faber M, Christensen J, Norrild B, Kjaer S
Acta Obstet Gynecol Scand
. 2013 Sep;
93(1):6-19.
PMID: 24033121
Objective: The role of human papillomavirus (HPV) in the pathogenesis of ovarian cancer is controversial, and conflicting results have been published. We conducted a systematic review and meta-analysis to estimate...